Respiradigm is a biomedical health company dedicated to improving lifelong outcomes for children at risk of respiratory and related immune diseases. Our lead products, the First Breath umbilical cord blood test helps parents understand their baby’s asthma risk and consider evidence-based options to strengthen their baby’s immune system and reduce the risk of a lifelong asthma burden.
The company’s First Breath™ test and associated action plan provides information and recommendations on environment, diet, and lifestyle factors as well as medications that will promote the development of a healthy immune system, and in doing so reduce the risk of the future development of respiratory infections, allergies, and asthma.
Company Details
Respiradigm Pty Ltd Questions
Respiradigm Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/respiradigm-pty-ltd
Respiradigm Pty Ltd has
3 employees.
View email and phone details for 3
employees at Respiradigm Pty Ltd.
Respiradigm Pty Ltd's industry is
Home Health Care Services
Respiradigm Pty Ltd's top competitors are
Carebridge,
Tedology,
Insigene,
Fiona Wood Foundation,
Agra Farming Technologies,
First Breath Health Pty Ltd,
Ideabank,
Vici Ventures, A Visagio Company,
Fileclo,
Carbonity.
Respiradigm Pty Ltd's categories are Home Health Care Services
Respiradigm Pty Ltd's founding year is 2021
